Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

Detection of TP53 Gene Mutations in Human Sarcomas

By Castresana J.S.   Rubio M.-P.   Gomez L.   Kreicbergs A.   Zetterberg A.   Barrios C.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 735-738

Elsevier

Access to resources Recommend Favorite

Identification of TP53 Gene Mutations in Uterine Corpus Cancer with Short Follow-up

By Koul A.   Borg A.   Pejovic T.   Bendahl P.-O.   Hogberg T.   Iosif C.S.   Killander D.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution

By                  

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-369

Spandidos Publications

Access to resources Recommend Favorite

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

By Nakanishi Ryota   Harada Jun   Tuul Munkhbold   Zhao Yan   Ando Koji   Saeki Hiroshi   Oki Eiji   Ohga Takefumi   Kitao Hiroyuki   Kakeji Yoshihiro   Maehara Yoshihiko  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1042-1048

Springer Publishing Company

Access to resources Recommend Favorite